Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin
about
Role of Glycans in Cancer Cells Undergoing Epithelial-Mesenchymal TransitionControl of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene familyProtein glycosylation in cancers and its potential therapeutic applications in neuroblastomaC1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin β1 glycosylation and activityIncrease of O-glycosylated oncofetal fibronectin in high glucose-induced epithelial-mesenchymal transition of cultured human epithelial cells.GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma.Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition processThe interconnectedness of cancer cell signaling.Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathwayProbing isoform-specific functions of polypeptide GalNAc-transferases using zinc finger nuclease glycoengineered SimpleCellsThe lectin domain of the polypeptide GalNAc transferase family of glycosyltransferases (ppGalNAc Ts) acts as a switch directing glycopeptide substrate glycosylation in an N- or C-terminal direction, further controlling mucin type O-glycosylationPolypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumours and poor prognosis in patients with renal cell carcinomas.Cancer subclonal genetic architecture as a key to personalized medicine.N-acetylgalactosaminyltransferases in cancer.Polypeptide N-acetylgalactosaminyltransferase-6 expression independently predicts poor overall survival in patients with lung adenocarcinoma after curative resectionThe Cosmc connection to the Tn antigen in cancer.Precision genome editing: a small revolution for glycobiology.Lectins as probes for assessing the accessibility of N-linked glycans in relation to the conformational changes of fibronectin.Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against CancerLoss of N-Acetylgalactosaminyltransferase-4 Orchestrates Oncogenic MicroRNA-9 in Hepatocellular Carcinoma.Specific N-glycan alterations are coupled in EMT induced by different density cultivation of MCF 10A epithelial cells.Specific N-glycan alterations are coupled in epithelial-mesenchymal transition induced by EGF in GE11 epithelial cells.GalNAc-T6 in the relationship with invasion ability of endometrial carcinomas and prognostic significance.GalNAc-T4 putatively modulates the estrogen regulatory network through FOXA1 glycosylation in human breast cancer cells.COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.Excess APP O-glycosylation by GalNAc-T6 decreases Aβ production.Induction of epithelial-mesenchymal transition with O-glycosylated oncofetal fibronectin.Polypeptide N-acetylgalactosaminyltransferase-6 expression in gastric cancer.Relevance of βGal-βGalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patients.Biological and biochemical properties of two Xenopus laevis N-acetylgalactosaminyltransferases with contrasting roles in embryogenesis.Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integrationPivotal role of MUC1 glycosylation by cigarette smoke in modulating disruption of airway adherens junctions in vitroGALNT6 expression enhances aggressive phenotypes of ovarian cancer cells by regulating EGFR activity.The molecular chaperone Cosmc enhances malignant behaviors of colon cancer cells via activation of Akt and ERK.De novo expression of human polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) in colon adenocarcinoma inhibits the differentiation of colonic epithelium.Core 3 mucin-type O-glycan restoration in colorectal cancer cells promotes MUC1/p53/miR-200c-dependent epithelial identity.Polypeptide-GalNAc-T6 expression predicts better overall survival in patients with colon cancer.O-linked mucin-type glycosylation in breast cancerCritical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells
P2860
Q26765748-61F5F3BC-1905-4971-B760-175DCA953318Q26864268-D7D5946A-AE7B-400B-903E-5202A8DC644FQ28069952-CA0FC85C-6056-4F9A-9B89-198971CD8E1FQ33999174-8CCB864D-8273-4850-8758-164955463BAAQ34673248-BE10F487-857A-4C48-9617-AC56B28B6BB2Q35067906-A2A968B2-D5AE-475E-8D2B-A45006D8C94FQ35470512-E5966B5C-5162-4F4B-8320-FFA1F79FF5B0Q35669733-B89814D1-274F-44AB-895C-CB42CA1F19BEQ35742481-122A07C6-B4D8-48CB-A52C-10957074BB24Q36056470-FBE4256C-FEF1-4E42-896C-5EF36FDC070CQ37000627-3AA2587C-85E9-4B3C-9419-CA7C64D23E43Q37040588-96FFE1B0-4DD7-471D-97CB-C2E11335AC44Q37448116-01C464F5-1ECB-4B14-92D6-06CB6A5915E5Q37619873-12C454BA-C3C3-4C09-9B5D-487CF31FCF17Q37688082-EDF0AC53-7902-49B0-932C-12C621142305Q38197051-FBA233EA-83AC-4DA4-B0D0-A29AC1E5DC0DQ38214809-DFF9A141-E825-4F6E-839B-DA65B5246C2BQ38297802-F6C4EB35-2067-4FF6-B4FD-1A39D62779EEQ38544783-68E635FA-441E-4280-BDAC-EA4387C2643EQ38722581-89323C5A-5F52-4B48-BABE-6D476D134ECEQ38723664-029E3B09-D203-4938-9B6F-55416E0DF226Q38728884-398F9E4A-FC33-4B72-AB56-2AABB9CC5564Q38755261-95A4C6F3-02E8-4BE7-89F2-F349B23213E9Q38821749-2014DA47-D274-4CB6-A847-253D51C43A05Q38869978-F435FF3A-9829-458F-988E-8071B0F5933AQ38981475-2468BCF6-0F1A-406F-84A4-A21EDE673D41Q39039911-376454FA-5821-4876-AEC4-DBBD2BF831B7Q39341014-AF9A7DE3-3C3B-4D98-A5AD-67A7956C7B28Q40108489-C49B2AC3-4934-43A8-B8EC-25674275EB2CQ40938494-2D146043-306A-4BB5-BADA-6D091F9DAA18Q41758636-1D962CAA-7DD0-45E0-9ED7-769442CE2C30Q41879186-853DB7FE-52DC-428A-8E8F-B5AA73A3656FQ42212778-2388E310-8B16-4C12-8BDF-3B055561AC26Q42335706-7C32896D-413B-4D20-AA34-FE6064613B98Q44392892-F19B462C-A5C8-47D6-8A0C-CBC7EE31882DQ47301558-379B9599-7FC2-40CB-BD44-FDD4DB7F4A9EQ48026410-01F7A917-83DF-48DB-840E-DEE7E618E327Q55284634-87E72085-932C-4C31-AEFC-D5483FD49178Q57107715-35B7B3AA-29A8-46D3-A14F-779F7D5F3953Q58757254-3017962E-6EB1-4EC6-BC63-63FF1825F873
P2860
Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Polypeptide N-acetylgalactosam ...... O-glycosylation of fibronectin
@ast
Polypeptide N-acetylgalactosam ...... O-glycosylation of fibronectin
@en
Polypeptide N-acetylgalactosam ...... O-glycosylation of fibronectin
@nl
type
label
Polypeptide N-acetylgalactosam ...... O-glycosylation of fibronectin
@ast
Polypeptide N-acetylgalactosam ...... O-glycosylation of fibronectin
@en
Polypeptide N-acetylgalactosam ...... O-glycosylation of fibronectin
@nl
prefLabel
Polypeptide N-acetylgalactosam ...... O-glycosylation of fibronectin
@ast
Polypeptide N-acetylgalactosam ...... O-glycosylation of fibronectin
@en
Polypeptide N-acetylgalactosam ...... O-glycosylation of fibronectin
@nl
P2093
P2860
P356
P1433
P1476
Polypeptide N-acetylgalactosam ...... O-glycosylation of fibronectin
@en
P2093
Jae-Hyun Park
Kyoko Kijima
Suyoun Chung
Toyomasa Katagiri
Yusuke Nakamura
P2860
P304
P356
10.1593/NEO.101440
P577
2011-04-01T00:00:00Z